A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Shona Pendse, MD, MMSc
Kowa Pharma Development Co.
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Dr. Greg Moloney
Vancouver, British Columbia, Canada
- Prism Eye Institute - Mississauga-Oakville
Oakville, Ontario, Canada
- Ottawa Hospital
Ottawa, Ontario, Canada
- Precision Cornea Centre
Ottawa, Ontario, Canada
- Rigshospitalet Glostrup-Nordre Ringvej 57
Glostrup Municipality, Capital, Denmark
- Aarhus Universitetshospital
Aarhus N, Central Jutland, Denmark
- Universitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany
- Universitätsklinikum Tübingen
Tübingen, Baden-Wurttemberg, Germany
- Universitatsklinkum Erlangen-Ulmenweg 18
Erlangen, Bavaria, Germany
- Uniklinik Köln
Cologne, North Rhine-Westphalia, Germany
- Universitatsklinikum Dusseldorf
Düsseldorf, North Rhine-Westphalia, Germany
- Universität Des Saarlandes
Homburg, Saarland, Germany
- Universitatsklinikum Leipzig
Leipzig, Saxony, Germany
- Lmu Klinikum Der Universität
München, Germany
- Hospital Universitario Germans Trias I Pujol
Badalona, Barcelona, Spain
- Althaia Xarxa Assistencial Universitaria Manresa
Manresa, Barcelona, Spain
- Hospital Arruzafa
Córdoba, Córdoba, Spain
- Instituto Oftalmologico Fernandez Vega
Oviedo, Principality of Asturias, Spain
- Institut Catala de Retina (icr)
Barcelona, Spain
- Instituto de Microcirugia Ocular
Barcelona, Spain
- Oftalvist - Barcelona
Barcelona, Spain
- the Royal Liverpool University Hospital
Liverpool, Lancashire, United Kingdom
- Moorfields Eye Hospital
London, London, City of, United Kingdom
- Royal Victoria Infirmary
Newcastle upon Tyne, Northumberland, United Kingdom
- Jules Stein Eye Institute
Los Angeles, California, United States
- Keck Hospital of Usc
Los Angeles, California, United States
- Macy Eye Center
Los Angeles, California, United States
- Byers Eye Institute at Stanford
Palo Alto, California, United States
- Sacramento Eye Consultants
Sacramento, California, United States
- Gorovoy Md Eye Specialists
Fort Myers, Florida, United States
- University of Florida
Gainesville, Florida, United States
- Bascom Palmer Eye Institute
Miami, Florida, United States
- Bascom Palmer Eye Institute - Naples
Naples, Florida, United States
- Eye Consultants of Atlanta
Atlanta, Georgia, United States
- Grene Vision Group
Wichita, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
- W Kellogg Eye Center
Ann Arbor, Michigan, United States
- Verdier Eye Center
Grand Rapids, Michigan, United States
- Vance Thompson Vision - Omaha
Omaha, Nebraska, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Mar 2023
- Primary completion
- 22 May 2025
- Completion
- 20 Feb 2026
- Last update posted
- 27 May 2026
- Registered enrollment
- 107
- Registry id
- NCT05795699
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.